| Literature DB >> 17540176 |
Anna A Sablina1, Wen Chen, Jason D Arroyo, Laura Corral, Melissa Hector, Sara E Bulmer, James A DeCaprio, William C Hahn.
Abstract
The serine-threonine protein phosphatase 2A (PP2A) is a heterotrimeric enzyme family that regulates numerous signaling pathways. Biallelic mutations of the structural PP2A Abeta subunit occur in several types of human tumors; however, the functional consequences of these cancer-associated PP2A Abeta mutations in cell transformation remain undefined. Here we show that suppression of PP2A Abeta expression permits immortalized human cells to achieve a tumorigenic state. Cancer-associated Abeta mutants fail to reverse tumorigenic phenotype induced by PP2A Abeta suppression, indicating that these mutants function as null alleles. Wild-type PP2A Abeta but not cancer-derived Abeta mutants form a complex with the small GTPase RalA. PP2A Abeta-containing complexes dephosphorylate RalA at Ser183 and Ser194, inactivating RalA and abolishing its transforming function. These observations identify PP2A Abeta as a tumor suppressor gene that transforms immortalized human cells by regulating the function of RalA.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17540176 PMCID: PMC1945132 DOI: 10.1016/j.cell.2007.03.047
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582